Abstract:Effect of converting ozonation to E-peroxone was studied on pharmaceutical removal. • A QSAR model was developed for selected 89 pharmaceuticals of special concern. • Both processes abated the pharmaceuticals of moderate and high kO3 quickly. • E-peroxone process accelerated the elimination of pharmaceuticals with low k O3. • Developed QSAR model reliably predicted kO3 of 418 out of 491 pharmaceuticals. The abatements of 89 pharmaceuticals in secondary effluent by ozonation and the electro-peroxone (E-peroxone) process were investigated. Based on the results, a quantitative structure-activity relationship (QSAR) model was developed to explore relationship between chemical structure of pharmaceuticals and their oxidation rates by ozone. The orthogonal projection to latent structure (OPLS) method was used to identify relevant chemical descriptors of the pharmaceuticals, from large number of descriptors, for model development. The resulting QSAR model, based on 44 molecular descriptors related to the ozone reactivity of the pharmaceuticals, showed high goodness of fit (R2 = 0.963) and predictive power (Q2 = 0.84). After validation, the model was used to predict second-order rate constants of 491 pharmaceuticals of special concern ( kO3) including the 89 studied experimentally. The predicted k O3 values and experimentally determined pseudo-first order rate constants of the pharmaceuticals’ abatement during ozonation (kOZ) and the E-peroxone process (kEP) were then used to assess effects of switching from ozonation to the E-peroxone process on removal of these pharmaceuticals. The results indicate that the E-peroxone process could accelerate the abatement of pharmaceuticals with relatively low ozone reactivity ( kO32 M-1·s−1) than ozonation (3–10 min versus 5–20 min). The validated QSAR model predicted 66 pharmaceuticals to be highly O3-resistant. The developed QSAR model may be used to estimate the ozone reactivity of pharmaceuticals of diverse chemistry and thus predict their fate in ozone-based processes.

Alamethicin: a peptide model for voltage gating and protein-membrane interactions.

Ozonation of Trimethoprim in Aqueous Solution: Identification of Reaction Products and Their Toxicity

Ozonation of carbamazepine, diclofenac, sulfamethoxazole and trimethoprim and formation of major oxidation products

Degradation of veterinary antibiotics by the ozonation process: Product identification and ecotoxicity assessment

Efficiency of ozonation and sulfate radical - AOP for removal of pharmaceuticals, corrosion inhibitors, x-ray contrast media and perfluorinated compounds from reverse osmosis concentrates

Oxidation of emerging biocides and antibiotics in wastewater by ozonation and the electro-peroxone process

Identification of Resistant Pharmaceuticals in Ozonation Using QSAR Modeling and Their Fate in Electro-Peroxone Process

Oxygen dependent oxidation of trimethoprim by sulfate radical: Kinetic and mechanistic investigations

Combination of Ozonation and Electrolysis Process to Enhance Elimination of Thirty Structurally Diverse Pharmaceuticals in Aqueous Solution.

Reaction Kinetics of Ozone with Selected Pharmaceuticals and Their Removal Potential from a Secondary Treated Municipal Wastewater Effluent in the Great Lakes Basin

Ozonation of Tamoxifen and Toremifene: Reaction Kinetics and Transformation Products

Phototransformation of roxithromycin in the presence of dissolved organic matter: Characteriazation of the degradation products and toxicity evaluation

Removal of organic micropollutants from domestic wastewater: The effect of ozone-based advanced oxidation process on nanofiltration

Degradation of Sulfamethoxazole by Ozonation Combined with Ionizing Radiation

Transformation of macrolide antibiotics during chlorination process: Kinetics, degradation products, and comprehensive toxicity evaluation

External Oxidant-Free Remediation of Antibiotics: Activation of Oxygen Molecules to Generate Hydroxyl Radicals Using Co-Fe3S4 Nanoflowers

Comparison of the effectiveness of UV, UV/VUV photolysis, ozonation, and ozone/UV processes for the removal of sulfonamide antibiotics

Understanding the Ozonated Degradation of Sulfadimethoxine, Exploration of Reaction Site, and Classification of Degradation Products.

Elimination of Isothiazolinone Biocides in Reverse Osmosis Concentrate by Ozonation: A Two-Phase Kinetics and a Non-Linear Surrogate Model.

Ozonation of Antidepressant Fluoxetine and Its Metabolite Product Norfluoxetine: Kinetics, Intermediates and Toxicity

Mechanisms for simultaneous ozonation of sulfamethoxazole and natural organic matters in secondary effluent from sewage treatment plant